期刊文献+

survivin、bcl-2在宫颈癌和癌前病变组织中的表达及与人乳头瘤病毒16/18感染的相关性 被引量:8

Expression of survivin, bcl-2 in cervical carcinoma and its association with HPV16/18 infection
原文传递
导出
摘要 目的探讨宫颈癌中survivin、bcl-2、人乳头瘤病毒(HPV)16/18的表达及其相关性。方法采用原位杂交法检测74例宫颈上皮内瘤变(CIN)、81例宫颈癌及20名正常宫颈组织(对照组)中survivin mRNA及HPV16/18 DNA的表达。采用免疫组织化学法检测各组中bcl-2蛋白的表达。结果survivinm RNA、bcl-2蛋白及HPV16/18在CIN中的表达率分别为44.6%、39.2%和41.0%,在宫颈癌中的表达率分别为77.8%、70.4%和81.2%。3者在正常宫颈组织、CIN及宫颈癌中的表达呈逐渐增强(P〈0.01)。survivinm RNA、bcl-2蛋白在CINⅢ级的阳性表达率高于CINⅠ~Ⅱ级,在宫颈癌中,Ⅱb~Ⅲ期的阳性表达率高于Ⅰ~Ⅱa期,低分化组的阳性表达率高于中至高分化组,差异均有统计学意义(均P分别〈0.05,〈0.01)。survivin在有淋巴结转移组的阳性率显著高于无转移组(P〈0.01),而bcl-2的表达则与淋巴结转移无关。两者均与宫颈癌的病理类型、肿块类型无关,HPV16/18感染与宫颈癌临床分期、组织学分级及肿块类型无关(P〉0.05)。在宫颈癌中survivin与bcl-2的表达与生存率均呈负相关,survivin与bcl-2及survivin与HPV16/18的表达呈正相关。结论survivin、bcl-2及HPV16/18的异常表达参与了宫颈癌的发生发展,联合survivin、bcl-2、HPV16/18有望为宫颈恶性肿瘤的早期诊断、手术及化疗疗效的评价、预后的判断提供有力的临床指导。 Objective To investigate the expression and the correlation of surviving, bcl-2 and HPV16/18 in cervical carcinoma. Methods Hybridization in situ was used to detect the expression of survivin mRNA and HPV16/18 DNA in 74 cases of CIN and 81 cases of cervical carcionma and 20 cases of normal cervical tissues. And immunohistochemical analysis was used to detect the expression of bcl-2 protein. Results The positive rates of survivin mRNA, bcl-2 and HPV16/18 in CIN were 44. 6%, 39. 2% and 41.0% respectively versus 77.8% , 70. 4% and 81.2% in cervical carcinoma. The above three indices gradually rose in normal cervical tissue, CIN and cervical carcinoma. The expression of survivin and bcl-2 in CINⅢ were obviously higher than those in CIN Ⅰ/Ⅱ. And it was obviously higher in cervical carcinoma with stage Ⅱ b- Ⅲ than those in stage Ⅰ - Ⅱ a. And it was also obviously higher in cervical carcinoma with a poor differentiation than those with a good or medium differentiation. The expression of survivin in cervical carcinoma with lymphatic metastasis was significantly higher than that without lymphatic metastasis. There were no relationship between the expression of survivin or bcl-2 and the pathological type or tumor type of cervical carcinoma. The infection of HPV16/18 also had nothing to do with the clinical stage or pathological type or tumor type of cervical carcinoma. Inverse correlation was both observed in the expression of survivin and bcl-2 with survival rate. Thus a positive correlation between surviving, bcl-2 and HPV 16/18 was observed in cervical carcinoma. Conclusion Survivin, bcl-2 and HPV16/18 participate in the development of cervical carcinoma. It may be a useful guide in early diagnosis of cervical carcinoma, evaluation of surgery and chemotherapy and prediction of outcome.
出处 《中华医学杂志》 CAS CSCD 北大核心 2010年第7期469-473,共5页 National Medical Journal of China
关键词 子宫肿瘤 宫颈上皮内瘤变 BCL-2基因 人乳头状瘤病毒 Uterine neoplasms Cervical intraepithelial neoplasia Genes, bcl-2 Human papilloma virus
  • 相关文献

参考文献13

  • 1Pilch H , Gunzel S , Schaffer U , et al . Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes- correlation with clinico-pathological parameters and prognostic significance. Zentralbl Gynakol,2001 , 123:91-101.
  • 2Sasaki T, Lopes MB, Hankins GR, et al. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system. Acta Neuropathol, 2002, 10 : 105-109.
  • 3Andersen MH, Svane IM, Becker JC, et al. The universal character of the tumor-associated antigen survivin. Clin Cancer Res, 2007, 13 : 5991-5994.
  • 4Kleinberg L, Florenes VA, Nesland JM, et al. Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions. Am J Clin Pathol ,2007,128:389-397.
  • 5Kim HS, Shiraki K, Park SH. Expression of Survivin in CIN and invasive squamous cell carcinoma of uterine cervix. Anticancer Res, 2002,22:805-808.
  • 6Chen ZY, Liang K, Xie MX, et al. Induced apoptosis with ultrasound-mediated microbubble destruction and shRNA targeting survivin in transplanted tumors. Adv Ther, 2009,26: 99-106.
  • 7Sanz L , Garcia-Marco JA, Casanova B, et al. Bclo2 family gene modulation during spontaneous apoptosis of B-chronic lymphocytic leukemia cells. Biochem Biophys Res Commun,2004, 315:562- 567.
  • 8唐忠辉,蔡庆发,叶兴安.宫颈上皮癌变过程中bcl-2、c-erbB2和p53蛋白的表达[J].癌症,2003,22(10):1057-1061. 被引量:8
  • 9邓志敏,金黎,陈晶儿,杨琳,郝艳华,吴双珍.bcl-2和bax蛋白在宫颈上皮内瘤样变和宫颈癌中的表达及意义[J].广东医学,2007,28(4):549-550. 被引量:10
  • 10Siripong P, Hahnvajanawong C, Yahuafai J, et al. Induction of apoptosis by rhinacanthone isolated from Rhinacanthus nasutus roots in human cervical carcinoma cells. Biol Pharm Bull, 2009, 32: 1251-1260.

二级参考文献28

  • 1徐廷香,李西启,王剑波,邹积才.Bcl-2基因蛋白在子宫颈癌和子宫颈上皮内瘤样变中的表达[J].中华妇产科杂志,1997,32(2):115-116. 被引量:8
  • 2Hockenberg D, Nunez G, Milliman C, et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death[J]. Nature, 1990, 348 - 334.
  • 3Graninger WB, Seto M, Boutain B, et al. Expression of bcl-2 and bcl-21g fusin transcripts in nomal and neoplastic cells[J]. J Clinic lnvers, 1987, 80: 1512.
  • 4Reed JC. Bcl-2 and regulation of programmned cell death[J]. J Cell Biol, 1994, 124: 1.
  • 5Saeguse M, Takano Y, Hashimura M, et al. The possible role of bcl-2 expression in the progression of tumor of uterine cervix[J].Cancer, 1995, 76:2297 - 2303.
  • 6Pillai MR, Halabi S, Mckalip A, et al. The presence of human papillo-mavirus-16/-18E6, p53, and bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer[ J ]. Cancer Epidemiol Biomarker Prey, 1996, 5 (5): 329 - 335.
  • 7Chang JL, Tsao YP, Liu DW, et al. The expression of type 1 growth factor receptors in the squamoas neoplastic changes of uterine cervix[J]. Gynecol Oncol, 1999, 73:62 -71.
  • 8Stao S, ho K, Ozawa N, et al. Expression of c-myc, epidermal growth factor receptor and c-erbB2 in human endometrial carcinoma and cervical adenocarcinomal [J]. Tohoku J Exp Med,1991, 165(2): 137.
  • 9Hoffman B, Liebermann DA. Molecular controls of apoptosis:differentiation/growth arrest primary response genes,proto-oncogenes, and tumor suppresser genes as positive & negative modu-lators[J]. Oncogene, 1994, 9:1807 - 1812.
  • 10Dittmer D, Pati S, Zambetti G, et al. Gain of function mutations in p53[J]. Nat Genel, 1993,4:42 -46.

共引文献22

同被引文献82

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部